| Drug Name: | Deferoxamine (70-51-9) |
|---|---|
| PubChem ID: | 2973 |
| SMILES: | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O |
| InchiKey: | UBQYURCVBFRUQT-UHFFFAOYSA-N |
| Therapeutic Category: | Chelating Agents, Iron Chelating Agents, Sequestering Agents, Siderophores |
| Molecular Weight (dalton) | : | 560.693 |
| LogP | : | 0.9221 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 9 |
| Hydrogen Bond Donor Count | : | 6 |
| Total Polar Surface Area | : | 205.84 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category